查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1819861

2025-2033 年生物感测器市场报告（按产品、技术、应用、最终用途和地区）

Biosensors Market Report by Product, Technology, Application, End Use, and Region 2025-2033
出版日期: | 出版商: IMARC | 英文 140 Pages | 商品交期: 2-3个工作天内

价格

2024年，全球生物感测器市场规模达309亿美元。展望未来， IMARC Group预计到2033年，市场规模将达到570亿美元，2025-2033年期间的复合年增长率（CAGR）为6.97%。北美凭藉其强大的医疗基础设施、强劲的研究投入、对个人化医疗的高需求以及领先的生物感测器製造商和科技公司，引领市场发展。技术进步、慢性病盛行率上升、即时检验（POCT）需求成长、医疗、食品和环境监测领域应用的不断扩展、政府倡议、研发投入、可穿戴生物感测器的出现以及对精准医疗和个人化治疗方法的日益关注，都是有利于市场成长的一些因素。

随着全球人口老化，对可靠有效的医疗保健方案的需求日益增长。生物感测器对于疾病监测、糖尿病等慢性病管理以及早期诊断至关重要。随着个人化和预防性医疗保健日益受到关注，生物感测器在即时监测健康状况、改善患者治疗效果方面也变得至关重要。此外，非侵入式监测方法（例如穿戴式生物感测器）也备受追捧。这些设备无需侵入性方法即可持续监测，从而提高了患者的舒适度和依从性。这一趋势对于治疗糖尿病等慢性疾病尤其有利，使患者无需刺穿皮肤即可追踪血糖水平。此外，政府和私人组织都在大力资助生物感测器技术的研究计画。对医疗技术创新的投资，尤其是旨在改善公共卫生成果的医疗保健解决方案的投资，正在推动生物感测器领域的重大进步。这些资金援助促进了创新生物感测器应用的开发。

生物感测器市场趋势：

慢性病盛行率不断上升

糖尿病、心臟病和呼吸系统疾病等慢性疾病的发生率不断上升，推动了生物感测器市场的成长。持续监测对于控制症状、预防併发症以及改善患者的生活品质至关重要。生物感测器提供了一种实用的方法，可以即时监测重要的健康指标，从而有助于及时发现异常情况。例如，糖尿病患者可以使用连续血糖监测仪来监测血糖水平并调整胰岛素剂量。同样，心臟病患者也依赖生物感测器来追踪心率并识别心律不整。随着全球慢性疾病的日益流行，对能够提供持续健康监测的生物感测器的需求也日益增长。 2025年，Ottai推出了其基于人工智慧的可穿戴生物感测器，旨在持续监测和管理慢性疾病。该设备利用即时生物标誌物追踪、声控记录和人工智慧驱动的洞察，提供个人化的生活方式建议。它与健康应用程式集成，提供可扩展的、以患者为中心的护理解决方案。

生物过程监测的进展

生物过程监测技术的进步正在推动市场成长，尤其是在生物技术和製药行业。即时观察生物反应器过程对于维持细胞培养、发酵和各种生物技术应用的品质、精度和有效性至关重要。具有复杂功能的生物感测器，例如能够识别极低浓度的重要分子，正在提高生物过程的准确性。这些感测器有助于优化培养基配方和生物製程管理，这对于提高製药、生物技术和替代蛋白质等领域的产量至关重要。顺应这一趋势，Cultivated B 于 2025 年推出了人工智慧驱动的多通道生物感测器，用于即时监测生物反应器过程，从而提高细胞培养和发酵的准确性和效率。这些线上感测器可检测关键分子的超低浓度，并利用人工智慧优化培养基配方和生物製程控制。这项创新支持生物技术、製药和替代蛋白质领域的可扩展应用。

生物感测器灵敏度和小型化的创新

包括自发光生物感测器的发明和量子非弹性电子隧道技术的应用在内的技术进步，正在提升生物感测器识别极低浓度（甚至低至皮克级）生物分子的能力。这些进步使得即时、无标记诊断成为可能，并能提供卓越的准确性和更快的检测结果。高灵敏度、小型化和便携式设备的开发能力增强了生物感测器的潜在用途，使其能够应用于医疗保健和环境监测等各个领域。随着生物感测器效率和多功能性的不断提高，其在即时诊断和现场监测中的应用日益广泛，从而增强了生物感测器技术在医疗和工业领域的整合。 2025年，洛桑联邦理工学院（EPFL）的科学家利用量子非弹性电子穿隧技术开发了首款自发光生物感测器，无需外部光源即可在单一晶片上产生和侦测光。这款小巧、超灵敏的设备可以侦测皮克级的生物分子，是即时、无标记诊断的理想选择。这项创新有望为医疗和环境应用提供可扩展的手持式生物感测器。

生物感测器市场成长动力：

穿戴式装置的普及率不断提高

智慧手錶、健身追踪器和健康监测手环等穿戴式装置的日益普及，为市场带来了良好的前景。这些设备配备了先进的生物感测器，使用户能够持续监测心率、血糖水平和血氧饱和度等生命体征，从而提高他们更有效地管理健康的能力。穿戴式装置对于患有慢性疾病或註重健康的人群尤其有用，它们可以提供便利和即时的健康讯息，而无需定期就医。客製化健康追踪的需求，以及穿戴式科技的进步，例如更长的电池寿命和更高的感测器精度，正在拓展其应用范围。 2024年，Biolinq获得5,800万美元融资，用于改进其可穿戴皮内葡萄糖生物感测器，该感测器透过放置在皮下的微感测器追踪血糖水平和活动。这款突破性的装置旨在简化代谢健康监测，凸显了穿戴式装置在个人化医疗保健中日益增长的重要性。

政府措施和资金

政府计画和研发资金支持是推动生物感测器市场扩张的关键因素。鑑于生物感测器技术对医疗保健和环境监测的重要性，许多管理机构正在投入大量资源，以促进该领域的创新。这些投资旨在增强生物感测器的功能、提高精度并降低成本，从而促进其在各种应用领域的广泛普及。此外，公共部门和私营部门之间的合作对于推动生物感测器在个人化医疗、疾病监测和即时诊断领域的发展至关重要。一个值得注意的例子是宾州州立大学于2024年10月宣布获得150万美元的国家科学基金会（NSF）资助，旨在开发用于识别神经传导物质等分子的人工智慧生物感测器。该计划由Aida Ebrahimi教授指导，涵盖K-12 STEM推广、本科生研究以及与产业界的合作，彰显了学术界、产业界和政府共同推动生物感测器进步的努力。

提高健康意识

大众对健康保健意识的不断增强是推动生物感测器设备普及的关键因素。随着人们更主动关注自身健康，对个人健康追踪设备的需求也随之增长。越来越多的人开始关注监测心率、血糖水平和血压等重要指标，以改善健康状况并预防疾病。这种向自我监测的转变尤其源于对糖尿病和高血压等慢性疾病的早期识别需求。健身追踪器和智慧手錶等设备可以提供即时健康讯息，为整体健康状况提供关键洞察。顺应这一趋势，雅培于2024年6月获得美国食品药物管理局（FDA）批准，并在美国推出了其非处方连续血糖监测 (CGM) 生物感测器 Lingo。 Lingo 基于 FreeStyle Libre 技术，为非胰岛素使用者提供即时血糖追踪、健康洞察和习惯指导。随着预防保健意识的增强，生物感测器市场持续成长，使个人能够有效管理自身健康。

目录

第一章：前言

第二章：范围与方法

  • 研究目标
  • 利害关係人
  • 资料来源
    • 主要来源
    • 二手资料
  • 市场评估
    • 自下而上的方法
    • 自上而下的方法
  • 预测方法

第三章：执行摘要

第四章：简介

第五章：全球生物感测器市场

  • 市场概况
  • 市场表现
  • COVID-19的影响
  • 市场预测

第六章：市场区隔：依产品

  • 穿戴式生物感测器
  • 非穿戴式生物感测器

第七章：市场区隔：依技术

  • 电化学生物感测器
  • 光学生物感测器
  • 压电生物感测器
  • 热生物感测器
  • 奈米机械生物感测器
  • 其他的

第 8 章：市场区隔：按应用

  • 血糖测试
  • 胆固醇检测
  • 血气分析
  • 妊娠测试
  • 药物研发
  • 传染病检测
  • 其他的

第 9 章：市场区隔：最终用途别

  • 即时检验
  • 家庭医疗保健诊断
  • 研究实验室
  • 安全与生物防御
  • 其他的

第十章：市场细分：按地区

  • 北美洲
    • 美国
    • 加拿大
  • 亚太
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 印尼
    • 其他的
  • 欧洲
    • 德国
    • 法国
    • 英国
    • 义大利
    • 西班牙
    • 俄罗斯
    • 其他的
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他的
  • 中东和非洲

第 11 章：SWOT 分析

第 12 章：价值链分析

第 13 章：波特五力分析

第 14 章：价格分析

第 15 章：竞争格局

  • 市场结构
  • 关键参与者
  • 关键参与者简介
    • Abbott Laboratories
    • AgaMatrix Inc. (WaveForm Technologies Inc)
    • DuPont de Nemours Inc.
    • F. Hoffmann-La Roche AG
    • General Electric Company
    • LifeScan Inc. (Platinum Equity LLC)
    • Medtronic PLC
    • Nova Biomedical Corporation
    • PHC Holdings Corporation
    • Siemens AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112025A4130

The global biosensors market size reached USD 30.9 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 57.0 Billion by 2033, exhibiting a growth rate (CAGR) of 6.97% during 2025-2033. North America leads the market attributed to robust healthcare infrastructure, strong investment in research operations, high demand for personalized medicine, and the presence of leading biosensor manufacturers and tech companies. Technological advancements, rising prevalence of chronic diseases, increasing demand for point-of-care testing (POCT), the expanding applications in healthcare, food, and environmental monitoring, government initiatives, investments in research and development (R&D), emergence of wearable biosensors, and the growing focus on precision medicine and personalized treatment approaches are some of the factors favoring the market growth.

With the aging global population, there is a rise in the demand for dependable and effective healthcare options. Biosensors are essential for disease monitoring, chronic condition management, such as diabetes, and facilitating early diagnosis. As personalized and preventive healthcare gains attention, biosensors are becoming essential for monitoring health in real-time, enhancing patient results. In addition, non-invasive monitoring methods, like those employed in wearable biosensors, are sought after. These devices provide the benefit of ongoing monitoring without requiring invasive methods, enhancing patient comfort and adherence. This trend is especially advantageous for handling chronic illnesses, such as diabetes, enabling patients to track glucose levels without needing to puncture their skin. Apart from this, both governments and private organizations are significantly funding research initiatives in biosensor technologies. Investment in medical technology innovation, particularly in healthcare solutions aimed at enhancing public health outcomes, are resulting in substantial progress in biosensors. This financial assistance fosters the creation of innovative biosensor applications.

Biosensors Market Trends:

Increasing Prevalence of Chronic Diseases

The rising occurrence of chronic illnesses, like diabetes, heart diseases, and breathing disorders, is contributing to the growth of the biosensors market. Continuous monitoring is essential for managing symptoms, preventing complications, and enhancing patients' quality of life under these conditions. Biosensors offer a practical approach by facilitating instant monitoring of essential health indicators, which aids in the prompt identification of abnormalities. For instance, individuals with diabetes utilize continuous glucose monitors to oversee blood sugar levels and modify insulin amounts. Likewise, people with cardiac issues depend on biosensors to track heart rate and identify irregular rhythms. With the growing prevalence of chronic illnesses worldwide, the need for biosensors that provide continuous health monitoring is escalating. In 2025, Ottai launched its AI-powered wearable biosensor designed for continuous monitoring and management of chronic diseases. The device uses real-time biomarker tracking, voice-activated logging, and AI-driven insights to deliver personalized lifestyle recommendations. It integrates with health apps to offer a scalable, patient-centric care solution.

Advancements in Bioprocess Monitoring

Improvements in bioprocess monitoring are impelling the growth of the market, especially in the biotechnology and pharmaceutical industries. Real-time observation of bioreactor processes is crucial for maintaining the quality, precision, and effectiveness of cell culture, fermentation, and various biotechnological applications. Biosensors with sophisticated features, including identifying extremely low levels of important molecules, are improving the accuracy of bioprocesses. These sensors facilitate the optimization of media formulation and bioprocess management, vital for increasing production in sectors, such as pharmaceuticals, biotechnology, and alternative proteins. In line with this trend, in 2025, The Cultivated B launched AI-driven multi-channel biosensors for real-time monitoring of bioreactor processes, enhancing accuracy and efficiency in cell culture and fermentation. These inline sensors detect ultra-low concentrations of key molecules and use AI to optimize media formulation and bioprocess control. The innovation supports scalable applications across biotech, pharma, and alternative proteins.

Innovation in Biosensor Sensitivity and Miniaturization

Technological progress, including the creation of self-illuminating biosensors and the application of quantum inelastic electron tunneling, is improving the capacity of biosensors to identify biomolecules at remarkably low concentrations, even down to the picogram level. These advancements allow for instantaneous, label-free diagnostics, providing excellent accuracy and quicker outcomes. The capacity to develop highly sensitive, small, and portable devices enhances the possible uses of biosensors, making them applicable across various sectors, such as healthcare and environmental monitoring. With the growing efficiency and versatility of biosensors, their application in point-of-care diagnostics and on-site monitoring is rising, enhancing the integration of biosensor technology in medical and industrial fields. In 2025, scientists at EPFL developed the first self-illuminating biosensor using quantum inelastic electron tunneling, enabling light generation and detection on a single chip without external light sources. This compact, ultra-sensitive device detects biomolecules at picogram levels, ideal for real-time, label-free diagnostics. The innovation promises scalable, handheld biosensors for medical and environmental applications.

Biosensors Market Growth Driver:

Increasing Adoption of Wearable Devices

The growing use of wearable gadgets like smartwatches, fitness trackers, and health-monitoring bands is offering a favorable market outlook. These gadgets, equipped with sophisticated biosensors, allow users to consistently monitor vital signs like heart rate, glucose levels, and oxygen saturation, enhancing their ability to manage health more efficiently. Wearable devices are especially useful for people with chronic illnesses or those prioritizing wellness, providing convenience and immediate health information without the need for regular doctor appointments. The need for tailored health tracking, along with enhancements in wearable tech, such as better battery longevity and sensor precision, is broadening their application. In 2024, Biolinq secured $58 million to enhance its wearable intradermal glucose biosensor, which tracks glucose levels and activity through microsensors placed under the skin. This groundbreaking gadget aimed to streamline metabolic health monitoring, emphasizing the increasing importance of wearables in individualized healthcare.

Government Initiatives and Funding

Government programs and financial support for research and development (R&D) are essential elements propelling the expansion of the biosensors market. Acknowledging the significance of biosensor technologies for healthcare and environmental monitoring, numerous governing bodies are dedicating substantial resources to foster innovation in this area. These investments aim to enhance biosensor functionality, increase precision, and reduce costs, thereby facilitating broader accessibility for various applications. Furthermore, collaborations between the public and private sectors are crucial for advancing biosensors in personalized medicine, disease monitoring, and point-of-care diagnostics. A notable example is Penn State's announcement in October 2024 of a $1.5 million NSF grant aimed at developing AI-designed biosensors for identifying molecules, such as neurotransmitters. Directed by Professor Aida Ebrahimi, the initiative encompassed K-12 STEM outreach, undergraduate research, and partnerships with industry, highlighting the collective endeavor of academia, industry, and government to promote biosensor advancements.

Rising Awareness about Health and Wellness

The growing public awareness about health and wellness is a key factor driving the adoption of biosensor-enabled devices. As individuals take more initiative regarding their health, there is an increase in the need for personal health tracking devices. More people are becoming interested in monitoring essential indicators, like heart rate, glucose levels, and blood pressure, to improve their health and prevent medical problems. This transition towards self-monitoring is especially driven by the need for early identification of chronic illnesses such as diabetes and hypertension. Gadgets such as fitness trackers and smartwatches provide instant health information, offering crucial insights into overall well-being. In line with this trend, in 2024, Abbott launched Lingo, its over-the-counter continuous glucose monitoring (CGM) biosensor in the US, following FDA clearance in June. Built on FreeStyle Libre tech, Lingo offered real-time glucose tracking, health insights, and habit coaching for non-insulin users. With increased awareness of preventive care, the biosensor market continues to grow, enabling individuals to manage their health effectively.

Biosensors Industry Segmentation:

Breakup by Product:

  • Wearable Biosensors
  • Non-Wearable Biosensors

The wearable biosensors segment is driven by the increasing demand for continuous health monitoring and personalized medicine. Consumers are increasingly adopting wearable devices such as smartwatches and fitness trackers that incorporate biosensors to monitor vital signs, physical activity, and other health metrics in real-time. Advances in sensor technology, miniaturization, and wireless connectivity have enhanced the functionality and accuracy of wearable biosensors, making them more attractive to users. Additionally, the growing prevalence of chronic diseases and the aging population are fueling the need for remote patient monitoring and early detection of health issues, further boosting the adoption of wearable biosensors. The integration of biosensors with smartphones and other portable devices facilitates seamless data transmission and analysis, providing users and healthcare providers with valuable insights for managing health and wellness.

The non-wearable biosensors segment is driven by the increasing applications in medical diagnostics, environmental monitoring, and food safety. In medical diagnostics, non-wearable biosensors are widely used for detecting various biomarkers, pathogens, and diseases, offering rapid, accurate, and cost-effective solutions for clinical and laboratory settings. Environmental monitoring applications leverage non-wearable biosensors to detect pollutants, toxins, and other harmful substances in air, water, and soil, contributing to public health and safety. In the food industry, non-wearable biosensors are utilized for quality control and safety assurance by detecting contaminants and ensuring compliance with regulatory standards. The rising awareness about the importance of early disease detection, environmental protection, and food safety is driving the demand for non-wearable biosensors.

Breakup by Technology:

  • Electrochemical Biosensors
  • Optical Biosensors
  • Piezoelectric Biosensors
  • Thermal Biosensors
  • Nanomechanical Biosensors
  • Others

The electrochemical biosensors segment is driven by the increasing demand for highly sensitive and selective detection methods in medical diagnostics, environmental monitoring, and food safety. The ability of electrochemical biosensors to provide rapid, accurate, and cost-effective analysis makes them highly desirable across various applications. Advances in nanotechnology and materials science have further enhanced their performance, enabling the development of miniaturized and portable devices. Additionally, the rising prevalence of chronic diseases, such as diabetes, necessitates the widespread use of electrochemical biosensors for continuous glucose monitoring, thereby fueling market growth.

The optical biosensors segment is driven by the increasing need for high-throughput and label-free detection methods in research, clinical diagnostics, and environmental monitoring. Optical biosensors offer exceptional sensitivity and specificity, making them ideal for detecting a wide range of analytes, including biomolecules, pathogens, and pollutants. Advances in photonics and biophotonics have significantly improved the performance of optical biosensors, enabling real-time and multiplexed detection. The growing adoption of point-of-care testing and personalized medicine further boosts the demand for optical biosensors, as they provide rapid and accurate results.

The piezoelectric biosensors segment is driven by the increasing utilization in applications requiring the detection of mechanical changes due to their high sensitivity and rapid response time. These biosensors are particularly effective in detecting mass changes, making them valuable in various fields, including medical diagnostics, environmental monitoring, and industrial processes. The growing demand for portable and non-invasive diagnostic tools is fueling the adoption of piezoelectric biosensors. Furthermore, advancements in piezoelectric materials and microfabrication technologies have enhanced the performance and miniaturization of these sensors, broadening their application scope.

The thermal biosensors segment is driven by the increasing need for highly accurate and reliable temperature-based detection methods in biomedical and industrial applications. Thermal biosensors, which measure changes in temperature as a result of biochemical reactions, offer high sensitivity and specificity. They are widely used in monitoring metabolic activities, detecting pathogens, and assessing food quality. The advancements in microelectromechanical systems (MEMS) and nanotechnology have significantly improved the performance of thermal biosensors, enabling their miniaturization and integration into portable devices.

The nanomechanical biosensors segment is driven by the increasing demand for ultra-sensitive detection methods capable of measuring minute changes at the nanoscale. These biosensors leverage mechanical properties such as mass, stiffness, and surface stress to detect the presence of analytes with high precision. The growing applications in genomics, proteomics, and environmental monitoring are boosting the adoption of nanomechanical biosensors. Advances in nanotechnology and materials science have enabled the development of highly sensitive and miniaturized nanomechanical biosensors, expanding their utility in various fields.

The others segment, which includes emerging biosensor technologies such as magnetic, acoustic, and thermal biosensors, is driven by the increasing need for innovative and versatile detection methods across various industries. These biosensors offer unique advantages, including high sensitivity, specificity, and the ability to detect a wide range of analytes. The growing demand for advanced diagnostic tools, environmental monitoring systems, and food safety solutions is fueling the development and adoption of these biosensors.

Breakup by Application:

  • Blood Glucose Testing
  • Cholesterol Testing
  • Blood Gas Analysis
  • Pregnancy Testing
  • Drug Discovery
  • Infectious Disease Testing
  • Others

The glucose testing segment is driven by the increasing prevalence of diabetes worldwide, which necessitates continuous monitoring and management of blood glucose levels. Advances in biosensor technology have led to the development of more accurate, user-friendly, and cost-effective glucose monitoring devices, including continuous glucose monitors (CGMs) and self-monitoring blood glucose (SMBG) systems. These innovations have significantly improved patient compliance and outcomes by enabling real-time glucose tracking and data integration with digital health platforms.

The cholesterol testing segment is driven by the increasing incidence of cardiovascular diseases (CVDs), which are closely linked to high cholesterol levels. Early detection and management of cholesterol are crucial for preventing CVDs, leading to a higher demand for cholesterol testing biosensors. Technological advancements have resulted in more reliable and faster cholesterol testing devices, including portable and point-of-care systems that provide immediate results. Additionally, rising health consciousness, routine health check-ups, and the emphasis on preventive healthcare practices have spurred the adoption of cholesterol testing biosensors.

The blood gas analysis segment is driven by the increasing prevalence of respiratory and metabolic disorders that require precise monitoring of blood gas levels. Conditions such as chronic obstructive pulmonary disease (COPD), asthma, and renal diseases necessitate regular blood gas analysis to manage and adjust treatment plans effectively. Technological advancements have led to the development of portable and point-of-care blood gas analyzers, making it easier for healthcare providers to perform timely and accurate assessments. Furthermore, the growing adoption of these devices in emergency and critical care settings, where rapid decision-making is crucial, significantly contributes to the market's expansion.

The pregnancy testing segment is driven by the increasing demand for home-based and point-of-care diagnostic solutions that offer convenience and privacy. Technological advancements have led to the development of highly sensitive and easy-to-use pregnancy test kits that provide quick and accurate results. The rising awareness about reproductive health and the importance of early pregnancy detection for better prenatal care have also fueled the demand for these testing kits. Additionally, the increasing prevalence of planned pregnancies, coupled with the availability of affordable and accessible testing solutions, further boosts the market.

The drug discovery segment is driven by the increasing need for efficient and cost-effective methods to identify new therapeutic compounds and evaluate their efficacy and safety. Biosensors offer significant advantages in drug discovery by enabling real-time, high-throughput screening of potential drug candidates. Technological advancements have enhanced the sensitivity and specificity of biosensors, making them invaluable tools in the early stages of drug development. Additionally, the growing prevalence of chronic diseases and the demand for personalized medicine have spurred investment in biosensor technologies to accelerate drug discovery processes.

The infectious disease testing segment is driven by the increasing incidence of infectious diseases globally, necessitating rapid and accurate diagnostic solutions. Biosensors offer significant advantages in the early detection and monitoring of infectious agents, enabling timely intervention and containment. Technological advancements have led to the development of highly sensitive and portable biosensors that can detect a wide range of pathogens, including viruses, bacteria, and fungi. The ongoing threat of pandemics and emerging infectious diseases has further highlighted the importance of efficient diagnostic tools, driving investment and innovation in this segment.

The others segment, encompassing various applications such as environmental monitoring, food safety, and bioprocessing, is driven by the increasing need for real-time, accurate, and cost-effective analytical solutions. In environmental monitoring, biosensors are used to detect pollutants and contaminants, ensuring compliance with regulatory standards and safeguarding public health. In food safety, biosensors provide rapid detection of pathogens and toxins, ensuring the quality and safety of food products.

Breakup by End Use:

  • Point of Care Testing
  • Home Healthcare Diagnostics
  • Research Laboratories
  • Security and Biodefense
  • Others

The point-of-care testing (POCT) segment is driven by the increasing demand for rapid diagnostic results and the need for immediate clinical decision-making. This demand is fueled by the growing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which require continuous monitoring and timely management. Technological advancements in biosensors have made these devices more portable, user-friendly, and capable of delivering accurate results quickly, enhancing their adoption in decentralized settings like clinics, emergency rooms, and even patients' homes. Additionally, the emphasis on reducing healthcare costs and improving patient outcomes has led to a shift towards point-of-care testing, allowing for faster diagnosis and treatment, thus minimizing hospital visits and stays.

The home healthcare diagnostics segment is driven by the increasing preference for convenient and accessible healthcare solutions. With the rise in the aging population and the growing burden of chronic diseases, there is a significant demand for home-based diagnostic tools that enable continuous monitoring and management of health conditions without frequent hospital visits. Advances in biosensor technology have facilitated the development of portable, easy-to-use devices that patients can operate independently, ensuring real-time health monitoring and early detection of potential health issues.

The research laboratories segment is driven by the increasing need for advanced diagnostic and analytical tools in scientific research and development. Biosensors play a crucial role in various research applications, including disease pathology, drug development, environmental monitoring, and biotechnology. The precision, sensitivity, and versatility of biosensors make them indispensable in detecting and quantifying biological molecules and pathogens, facilitating groundbreaking research and innovation. The continuous advancement in biosensor technology, including the integration of nanotechnology and microfluidics, enhances their performance, making them even more valuable in research settings.

The security and biodefense segment is driven by the increasing concerns over bioterrorism, infectious disease outbreaks, and the need for robust public safety measures. Biosensors are critical in this context due to their ability to provide rapid, accurate detection of biological and chemical threats, enabling timely response and mitigation. Governments and defense organizations invest heavily in biosensor technology to enhance national security and safeguard public health. The development of portable and real-time biosensors supports field deployment, making them essential tools for military and homeland security operations.

The others segment is driven by the increasing demand for biosensors in diverse applications beyond traditional healthcare and security uses. This includes industries such as agriculture, food and beverage, environmental monitoring, and industrial processes. In agriculture, biosensors are used for soil and crop health monitoring, ensuring optimal yield and quality. In the food and beverage industry, they are crucial for quality control and safety assurance by detecting contaminants and pathogens. Environmental monitoring applications benefit from biosensors' ability to detect pollutants and toxins in air, water, and soil, contributing to sustainability efforts.

Breakup by Region:

  • North America
    • United States
    • Canada
  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

The market research report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa.

The North America regional market is driven by the increasing prevalence of chronic diseases such as diabetes and cardiovascular conditions, which necessitate advanced diagnostic tools. Additionally, the region benefits from robust healthcare infrastructure, significant investments in research and development, and the presence of major biosensor manufacturers. Government initiatives to promote personalized medicine and growing adoption of wearable biosensors for health monitoring further propel market growth. The high awareness and acceptance of new technologies among consumers and healthcare providers also contribute to the expanding biosensors market in North America.

The Europe regional market is driven by the increasing focus on early disease detection and preventive healthcare, supported by substantial government funding and initiatives. The region's strong regulatory framework ensures high standards for biosensor development and application. Additionally, Europe's aging population contributes to a rising demand for advanced diagnostic solutions, while the presence of leading biosensor companies and extensive research activities foster innovation. Growing applications in environmental monitoring and food safety, along with collaboration between academic institutions and industry players, further accelerate market growth in Europe.

The Asia Pacific regional market is driven by the increasing healthcare needs due to a large and rapidly aging population, along with the rising prevalence of chronic diseases. Economic growth and improving healthcare infrastructure in countries like China and India enhance access to advanced diagnostic tools. Government initiatives to boost healthcare innovation and substantial investments in biosensor research and development also play a crucial role. Moreover, the expanding applications of biosensors in environmental monitoring and food safety, coupled with growing consumer awareness, contribute to the robust market growth in the Asia Pacific region.

The Latin America regional market is driven by the increasing demand for advanced healthcare solutions to address the rising incidence of chronic diseases. Improving healthcare infrastructure and government initiatives aimed at enhancing healthcare access and quality stimulate market growth. Additionally, growing awareness about the benefits of early disease detection and the adoption of point-of-care testing drive the demand for biosensors. The presence of local biosensor manufacturers and ongoing research and development activities further support market expansion.

The Middle East and Africa regional market is driven by the increasing need for improved healthcare services amidst a growing prevalence of chronic diseases and infectious conditions. Government efforts to enhance healthcare infrastructure and increase investments in medical technology bolster the market. Additionally, the adoption of advanced diagnostic tools and point-of-care testing is gaining traction. Rising awareness about early disease detection, coupled with international collaborations and partnerships, supports market growth.

Competitive Landscape:

  • The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the biosensors include Abbott Laboratories, AgaMatrix Inc. (WaveForm Technologies Inc), DuPont de Nemours Inc., F. Hoffmann-La Roche AG, General Electric Company, LifeScan Inc. (Platinum Equity LLC), Medtronic PLC, Nova Biomedical Corporation, PHC Holdings Corporation, Siemens AG, Thermo Fisher Scientific Inc., etc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

  • Key players in the global biosensors market are actively pursuing various strategies to strengthen their market positions and drive growth. They are heavily investing in R&D to innovate and enhance the sensitivity, accuracy, and functionality of biosensors. Collaborations and partnerships with academic institutions, research organizations, and other industry stakeholders are being forged to accelerate technological advancements and expand application areas. Companies are also focusing on strategic acquisitions and mergers to broaden their product portfolios and gain access to new markets. Additionally, there is a strong emphasis on developing wearable and portable biosensors to cater to the rising demand for point-of-care testing and remote health monitoring. Marketing efforts are geared towards increasing awareness and adoption of biosensors across diverse sectors such as healthcare, environmental monitoring, and food safety. Regulatory compliance and obtaining necessary approvals are also prioritized to ensure product reliability and market acceptance.

Key Questions Answered in This Report

  • 1.What was the size of the global biosensors market in 2024?
  • 2.What is the expected growth rate of the global biosensors market during 2025-2033?
  • 3.What are the key factors driving the global biosensors market?
  • 4.What has been the impact of COVID-19 on the global biosensors market?
  • 5.What is the breakup of the global biosensors market based on the product?
  • 6.What is the breakup of the global biosensors market based on the technology?
  • 7.What is the breakup of the global biosensors market based on the application?
  • 8.What is the breakup of the global biosensors market based on the end use?
  • 9.What are the key regions in the global biosensors market?
  • 10.Who are the key players/companies in the global biosensors market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Biosensors Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Product

  • 6.1 Wearable Biosensors
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Non-Wearable Biosensors
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Technology

  • 7.1 Electrochemical Biosensors
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Optical Biosensors
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Piezoelectric Biosensors
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Thermal Biosensors
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Nanomechanical Biosensors
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast
  • 7.6 Others
    • 7.6.1 Market Trends
    • 7.6.2 Market Forecast

8 Market Breakup by Application

  • 8.1 Blood Glucose Testing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Cholesterol Testing
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Blood Gas Analysis
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Pregnancy Testing
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Drug Discovery
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast
  • 8.6 Infectious Disease Testing
    • 8.6.1 Market Trends
    • 8.6.2 Market Forecast
  • 8.7 Others
    • 8.7.1 Market Trends
    • 8.7.2 Market Forecast

9 Market Breakup by End Use

  • 9.1 Point of Care Testing
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Home Healthcare Diagnostics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Research Laboratories
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Security and Biodefense
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast
  • 9.5 Others
    • 9.5.1 Market Trends
    • 9.5.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia-Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 Abbott Laboratories
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
      • 15.3.1.3 Financials
      • 15.3.1.4 SWOT Analysis
    • 15.3.2 AgaMatrix Inc. (WaveForm Technologies Inc)
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
    • 15.3.3 DuPont de Nemours Inc.
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 F. Hoffmann-La Roche AG
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
    • 15.3.5 General Electric Company
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 LifeScan Inc. (Platinum Equity LLC)
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
    • 15.3.7 Medtronic PLC
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
    • 15.3.8 Nova Biomedical Corporation
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
    • 15.3.9 PHC Holdings Corporation
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Siemens AG
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
      • 15.3.10.3 Financials
      • 15.3.10.4 SWOT Analysis
    • 15.3.11 Thermo Fisher Scientific Inc.
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
      • 15.3.11.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Biosensors Market: Major Drivers and Challenges
  • Figure 2: Global: Biosensors Market: Sales Value (in Billion USD), 2019-2024
  • Figure 3: Global: Biosensors Market Forecast: Sales Value (in Billion USD), 2025-2033
  • Figure 4: Global: Biosensors Market: Breakup by Product (in %), 2024
  • Figure 5: Global: Biosensors Market: Breakup by Technology (in %), 2024
  • Figure 6: Global: Biosensors Market: Breakup by Application (in %), 2024
  • Figure 7: Global: Biosensors Market: Breakup by End Use (in %), 2024
  • Figure 8: Global: Biosensors Market: Breakup by Region (in %), 2024
  • Figure 9: Global: Biosensors (Wearable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 10: Global: Biosensors (Wearable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 11: Global: Biosensors (Non-Wearable) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 12: Global: Biosensors (Non-Wearable) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 13: Global: Biosensors (Electrochemical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 14: Global: Biosensors (Electrochemical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 15: Global: Biosensors (Optical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 16: Global: Biosensors (Optical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 17: Global: Biosensors (Piezoelectric) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 18: Global: Biosensors (Piezoelectric) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 19: Global: Biosensors (Thermal) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 20: Global: Biosensors (Thermal) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 21: Global: Biosensors (Nanomechanical) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 22: Global: Biosensors (Nanomechanical) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 23: Global: Biosensors (Other Technologies) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 24: Global: Biosensors (Other Technologies) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 25: Global: Biosensors (Blood Glucose Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 26: Global: Biosensors (Blood Glucose Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 27: Global: Biosensors (Cholesterol Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 28: Global: Biosensors (Cholesterol Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 29: Global: Biosensors (Blood Gas Analysis) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 30: Global: Biosensors (Blood Gas Analysis) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 31: Global: Biosensors (Pregnancy Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 32: Global: Biosensors (Pregnancy Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 33: Global: Biosensors (Drug Discovery) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 34: Global: Biosensors (Drug Discovery) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 35: Global: Biosensors (Infectious Disease Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 36: Global: Biosensors (Infectious Disease Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 37: Global: Biosensors (Other Applications) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 38: Global: Biosensors (Other Applications) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 39: Global: Biosensors (Point of Care Testing) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 40: Global: Biosensors (Point of Care Testing) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 41: Global: Biosensors (Home Healthcare Diagnostics) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 42: Global: Biosensors (Home Healthcare Diagnostics) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 43: Global: Biosensors (Research Laboratories) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 44: Global: Biosensors (Research Laboratories) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 45: Global: Biosensors (Security and Biodefense) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 46: Global: Biosensors (Security and Biodefense) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 47: Global: Biosensors (Other End uses) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 48: Global: Biosensors (Other End uses) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 49: North America: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 50: North America: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 51: United States: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 52: United States: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 53: Canada: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 54: Canada: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 55: Asia-Pacific: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 56: Asia-Pacific: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 57: China: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 58: China: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 59: Japan: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 60: Japan: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 61: India: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 62: India: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 63: South Korea: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 64: South Korea: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 65: Australia: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 66: Australia: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 67: Indonesia: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 68: Indonesia: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 69: Others: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 70: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 71: Europe: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 72: Europe: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 73: Germany: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 74: Germany: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 75: France: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 76: France: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 77: United Kingdom: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 78: United Kingdom: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 79: Italy: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 80: Italy: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 81: Spain: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 82: Spain: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Russia: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 84: Russia: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 85: Others: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 86: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 87: Latin America: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 88: Latin America: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 89: Brazil: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 90: Brazil: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 91: Mexico: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 92: Mexico: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 93: Others: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 94: Others: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 95: Middle East and Africa: Biosensors Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 96: Middle East and Africa: Biosensors Market: Breakup by Country (in %), 2024
  • Figure 97: Middle East and Africa: Biosensors Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 98: Global: Biosensors Industry: SWOT Analysis
  • Figure 99: Global: Biosensors Industry: Value Chain Analysis
  • Figure 100: Global: Biosensors Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Biosensors Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Biosensors Market Forecast: Breakup by Product (in Million USD), 2025-2033
  • Table 3: Global: Biosensors Market Forecast: Breakup by Technology (in Million USD), 2025-2033
  • Table 4: Global: Biosensors Market Forecast: Breakup by Application (in Million USD), 2025-2033
  • Table 5: Global: Biosensors Market Forecast: Breakup by End Use (in Million USD), 2025-2033
  • Table 6: Global: Biosensors Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 7: Global: Biosensors Market: Competitive Structure
  • Table 8: Global: Biosensors Market: Key Players